Clinical Trials Directory

Trials / Completed

CompletedNCT03005964

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

A Multi-Center, Double-Blind, Randomized, Vehicle- Controlled, Parallel-Group Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
AmDerma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of plaque psoriasis

Conditions

Interventions

TypeNameDescription
DRUGAM001 Cream, 7.5%Active Cream
DRUGVehicle CreamPlacebo

Timeline

Start date
2016-12-01
Primary completion
2017-08-15
Completion
2017-09-04
First posted
2016-12-30
Last updated
2018-10-03

Locations

2 sites across 1 country: Dominican Republic

Source: ClinicalTrials.gov record NCT03005964. Inclusion in this directory is not an endorsement.

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis (NCT03005964) · Clinical Trials Directory